4//SEC Filing
SYNERGETICS USA INC 4
Accession 0001140361-15-037685
CIK 0000836429operating
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 2:19 PM ET
Size
8.2 KB
Accession
0001140361-15-037685
Insider Transaction Report
Form 4
Blankemeyer Robert H
Director
Transactions
- Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 totalExercise: $3.46Exp: 2023-12-13→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 totalExercise: $3.70Exp: 2024-12-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of September 1, 2015, by and among Valeant Pharmaceuticals International, Blue Subsidiary Corp. and Synergetics USA, Inc. (the "Merger Agreement"), on October 15, 2015, each option outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) was canceled in exchange for (i) a cash payment equal to the product of (A) the number of shares underlying the option and (B) the difference between $6.50, the cash consideration offered pursuant to the Merger Agreement, and the exercise price of the option; and (ii) one non-transferable contractual contingent value right per share underlying the option, which represents the right to receive up to two contingent payments, if any, of up to $1.00 in the aggregate, net to the holder in cash, upon the achievement of certain specified milestones within an agreed upon time period (less any applicable withholding taxes and without interest).
Documents
Issuer
SYNERGETICS USA INC
CIK 0000836429
Entity typeoperating
Related Parties
1- filerCIK 0000836429
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 2:19 PM ET
- Size
- 8.2 KB